Oragenics, Inc. (OGEN)
Largest Insider Buys in Sector
OGEN Stock Price History Chart
OGEN Stock Performance
About Oragenics, Inc.
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to …
Insider Activity of Oragenics, Inc.
Over the last 12 months, insiders at Oragenics, Inc. have bought $0 and sold $1,319 worth of Oragenics, Inc. stock.
On average, over the past 5 years, insiders at Oragenics, Inc. have bought $322,177 and sold $1.11M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,084 shares for transaction amount of $2,884 was made by Telling Fred () on 2022‑06‑17.
List of Insider Buy and Sell Transactions, Oragenics, Inc.
| 2024-12-06 | Sale | director | 3,597 0.0303% | $0.36 | $1,295 | -3.98% | ||
| 2024-12-06 | Sale | director | 66 0.0006% | $0.36 | $24 | -3.98% | ||
| 2023-11-30 | Sale | director | 3,500 0.3216% | $3.57 | $12,488 | -65.64% | ||
| 2022-12-30 | Sale | director | 42,357 0.1151% | $0.11 | $4,469 | -48.03% | ||
| 2022-12-29 | Sale | director | 36,648 0.1% | $0.11 | $3,885 | -48.03% | ||
| 2022-12-15 | Sale | director | 140,497 0.636% | $0.18 | $24,699 | -66.37% | ||
| 2022-12-14 | Sale | director | 29,503 0.1329% | $0.17 | $5,163 | -66.37% | ||
| 2022-12-09 | Sale | director | 48,795 0.2475% | $0.20 | $9,613 | -69.91% | ||
| 2022-12-08 | Sale | director | 13,036 0.0671% | $0.20 | $2,607 | -69.91% | ||
| 2022-11-30 | Sale | director | 200,000 0.9841% | $0.19 | $38,220 | -71.33% | ||
| 2022-11-29 | Sale | director | 200,000 0.9903% | $0.19 | $38,460 | -69.82% | ||
| 2022-06-17 | 10,084 0.0743% | $0.29 | $2,884 | -46.88% | ||||
| 2022-05-23 | director | 82,173 0.6123% | $0.29 | $23,780 | -31.03% | |||
| 2022-05-20 | 65,718 0.4799% | $0.28 | $18,638 | -28.57% | ||||
| 2022-05-19 | director | 56,806 0.4106% | $0.28 | $15,945 | -28.57% | |||
| 2022-05-18 | 15,303 0.1028% | $0.26 | $3,994 | -23.08% | ||||
| 2022-03-30 | director | 183,838 1.7008% | $0.36 | $66,053 | -33.33% | |||
| 2022-03-29 | Interim PEO, CFO | 20,000 0.1782% | $0.35 | $6,922 | -31.43% | |||
| 2021-12-31 | director | 799,100 9.7531% | $0.47 | $378,773 | -26.67% | |||
| 2021-12-30 | director | 200,900 2.3268% | $0.45 | $90,365 | -23.26% |
Insider Historical Profitability
| Telling Fred | director | 34748 0.2764% | $0.38 | 15 | 2 | <0.0001% |
| DUNTON ALAN W | director | 25623 0.2038% | $0.38 | 1 | 16 | <0.0001% |
| KIRK RANDAL J | 10 percent owner | 14481089 115.2026% | $0.38 | 3 | 0 | |
| HAWES GEORGE T | 10 percent owner | 10857235 86.3735% | $0.38 | 5 | 19 | |
| HILLMAN JEFFREY D | Director | 4202394 33.4317% | $0.38 | 1 | 2 |